Lifeward Ltd. (LFWD) Fair Value 2026

LFWD · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.6 /10

32 fundamental signals · 0 models active

Value Trap Risk

WARN (47/100)

Quick Summary — As of 2026-08-28, Lifeward Ltd. (LFWD) trades at $7.46. QOC: 5.6/10. Value Trap Risk: 47/100 (WARN). 0/13 models active.

Key Facts

Ticker
LFWD
Price
$7.46
Quality Score
5.6/10
Value Trap Risk
47/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 47 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give LFWD?

0 Intrinsic Value Models vs. Current Price ($7.46)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Lifeward Ltd. (LFWD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Lifeward Ltd. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About LFWD?

0 of 13 models are currently active for LFWD. See which stocks rank higher →

How Does LFWD Rank in Medical Devices?

Among 159 Medical Devices stocks, LFWD ranks #108 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

As a healthcare company, Lifeward Ltd. operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating LFWD should weigh these sector-specific dynamics alongside our model-derived fair values.

Is LFWD a Value Trap?

CirclFi's Value Trap algorithm assigns LFWD a score of 47/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Lifeward Ltd.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Lifeward Ltd.'s fundamental quality profile registers 5.6/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every LFWD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Lifeward Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

NNOXNano-X Imaging Ltd.QOC 5.6PACBPacific Biosciences of California, Inc.QOC 5.6QTIQT Imaging Holdings, Inc.QOC 5.6COCHEnvoy Medical, Inc.QOC 5.6SINTSintx Technologies, Inc.QOC 5.7PLSMPulsenmore Ltd.QOC 5.6MOBIMobia Medical, Inc.QOC 3.9LIVNLivaNova PLCQOC 8.1TELATELA Bio, Inc.QOC 6.5IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: NNOX · PACB · QTI · COCH · SINT · PLSM · MOBI · LIVN · TELA · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to LFWD?

5 companies across all industries closest to LFWD’s Quality of Company score of 5.6/10.

KLARKlarna Group plcQOC 5.6FATEFate Therapeutics, Inc.QOC 5.6CYCNCyclerion Therapeutics, Inc.QOC 5.6TMDETMD Energy LimitedQOC 5.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: KLAR · FATE · CYCN · TMDE · NVDA

Where Does LFWD Sit in CirclFi's Medical Devices Rankings?

LFWD is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Lifeward Ltd.’s Valuation?

What is Lifeward Ltd.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Lifeward Ltd. (LFWD). The Quality of Company score is 5.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is LFWD overvalued or undervalued right now?

At $7.46, 0 of 0 active models suggest LFWD may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Lifeward Ltd.'s business model in Medical Devices.

What does a Quality of Company score of 5.6 mean for LFWD?

Lifeward Ltd.'s QOC of 5.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on LFWD?

CirclFi analyzes LFWD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is LFWD a value trap in 2026?

Lifeward Ltd.'s Value Trap score is 47/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Lifeward Ltd. (LFWD) a Quality of Company score of 5.6/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/LFWD/ · Methodology
Primary sources for this LFWD valuation
  • Financial statements: Lifeward Ltd. 10-K and 10-Q filings on SEC EDGAR (CIK 0001607962) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for LFWD as of ; valuations recomputed .